nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—Pemphigoid—Fluorouracil—head and neck cancer	0.134	0.134	CcSEcCtD
Nadolol—Colitis ischaemic—Docetaxel—head and neck cancer	0.0412	0.0412	CcSEcCtD
Nadolol—Slurred speech—Fluorouracil—head and neck cancer	0.0375	0.0375	CcSEcCtD
Nadolol—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.0246	0.0246	CcSEcCtD
Nadolol—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0208	0.0208	CcSEcCtD
Nadolol—Disorientation—Hydroxyurea—head and neck cancer	0.0189	0.0189	CcSEcCtD
Nadolol—Dysarthria—Fluorouracil—head and neck cancer	0.0177	0.0177	CcSEcCtD
Nadolol—Throat sore—Docetaxel—head and neck cancer	0.0168	0.0168	CcSEcCtD
Nadolol—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.0167	0.0167	CcSEcCtD
Nadolol—Depression—Vinblastine—head and neck cancer	0.0143	0.0143	CcSEcCtD
Nadolol—Disorientation—Fluorouracil—head and neck cancer	0.0136	0.0136	CcSEcCtD
Nadolol—Agranulocytosis—Vinblastine—head and neck cancer	0.0133	0.0133	CcSEcCtD
Nadolol—Oropharyngeal pain—Docetaxel—head and neck cancer	0.0133	0.0133	CcSEcCtD
Nadolol—Weight increased—Hydroxyurea—head and neck cancer	0.0133	0.0133	CcSEcCtD
Nadolol—Amnesia—Fluorouracil—head and neck cancer	0.013	0.013	CcSEcCtD
Nadolol—Cardiac failure—Fluorouracil—head and neck cancer	0.0125	0.0125	CcSEcCtD
Nadolol—Lethargy—Fluorouracil—head and neck cancer	0.0124	0.0124	CcSEcCtD
Nadolol—Hallucination—Hydroxyurea—head and neck cancer	0.0116	0.0116	CcSEcCtD
Nadolol—Irritability—Fluorouracil—head and neck cancer	0.0116	0.0116	CcSEcCtD
Nadolol—Fluid retention—Docetaxel—head and neck cancer	0.0115	0.0115	CcSEcCtD
Nadolol—Alopecia—Vinblastine—head and neck cancer	0.0113	0.0113	CcSEcCtD
Nadolol—Dry skin—Fluorouracil—head and neck cancer	0.0112	0.0112	CcSEcCtD
Nadolol—Pulmonary oedema—Docetaxel—head and neck cancer	0.0108	0.0108	CcSEcCtD
Nadolol—Alopecia—Hydroxyurea—head and neck cancer	0.0103	0.0103	CcSEcCtD
Nadolol—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00969	0.00969	CcSEcCtD
Nadolol—Hypertension—Vinblastine—head and neck cancer	0.00965	0.00965	CcSEcCtD
Nadolol—Visual disturbance—Docetaxel—head and neck cancer	0.00928	0.00928	CcSEcCtD
Nadolol—Conjunctivitis—Fluorouracil—head and neck cancer	0.00912	0.00912	CcSEcCtD
Nadolol—Cardiac failure—Docetaxel—head and neck cancer	0.00901	0.00901	CcSEcCtD
Nadolol—Lethargy—Docetaxel—head and neck cancer	0.00897	0.00897	CcSEcCtD
Nadolol—Agranulocytosis—Fluorouracil—head and neck cancer	0.00876	0.00876	CcSEcCtD
Nadolol—Anorexia—Vinblastine—head and neck cancer	0.00869	0.00869	CcSEcCtD
Nadolol—Oedema—Hydroxyurea—head and neck cancer	0.00832	0.00832	CcSEcCtD
Nadolol—Paraesthesia—Vinblastine—head and neck cancer	0.00819	0.00819	CcSEcCtD
Nadolol—Dry skin—Docetaxel—head and neck cancer	0.00806	0.00806	CcSEcCtD
Nadolol—Anorexia—Hydroxyurea—head and neck cancer	0.00793	0.00793	CcSEcCtD
Nadolol—Decreased appetite—Vinblastine—head and neck cancer	0.00793	0.00793	CcSEcCtD
Nadolol—Pain—Vinblastine—head and neck cancer	0.0078	0.0078	CcSEcCtD
Nadolol—Constipation—Vinblastine—head and neck cancer	0.0078	0.0078	CcSEcCtD
Nadolol—Bronchospasm—Docetaxel—head and neck cancer	0.00747	0.00747	CcSEcCtD
Nadolol—Alopecia—Fluorouracil—head and neck cancer	0.00745	0.00745	CcSEcCtD
Nadolol—Dyspnoea—Hydroxyurea—head and neck cancer	0.00742	0.00742	CcSEcCtD
Nadolol—Dyspepsia—Hydroxyurea—head and neck cancer	0.00732	0.00732	CcSEcCtD
Nadolol—Decreased appetite—Hydroxyurea—head and neck cancer	0.00723	0.00723	CcSEcCtD
Nadolol—Fatigue—Hydroxyurea—head and neck cancer	0.00717	0.00717	CcSEcCtD
Nadolol—Pain—Hydroxyurea—head and neck cancer	0.00711	0.00711	CcSEcCtD
Nadolol—Constipation—Hydroxyurea—head and neck cancer	0.00711	0.00711	CcSEcCtD
Nadolol—Weight increased—Docetaxel—head and neck cancer	0.00692	0.00692	CcSEcCtD
Nadolol—Vision blurred—Fluorouracil—head and neck cancer	0.00691	0.00691	CcSEcCtD
Nadolol—Conjunctivitis—Docetaxel—head and neck cancer	0.00659	0.00659	CcSEcCtD
Nadolol—Body temperature increased—Hydroxyurea—head and neck cancer	0.00658	0.00658	CcSEcCtD
Nadolol—Asthenia—Vinblastine—head and neck cancer	0.00654	0.00654	CcSEcCtD
Nadolol—Agranulocytosis—Docetaxel—head and neck cancer	0.00632	0.00632	CcSEcCtD
Nadolol—Chest pain—Fluorouracil—head and neck cancer	0.00625	0.00625	CcSEcCtD
Nadolol—Diarrhoea—Vinblastine—head and neck cancer	0.00624	0.00624	CcSEcCtD
Nadolol—Dizziness—Vinblastine—head and neck cancer	0.00603	0.00603	CcSEcCtD
Nadolol—Oedema—Fluorouracil—head and neck cancer	0.00599	0.00599	CcSEcCtD
Nadolol—Asthenia—Hydroxyurea—head and neck cancer	0.00597	0.00597	CcSEcCtD
Nadolol—Visual impairment—Docetaxel—head and neck cancer	0.00586	0.00586	CcSEcCtD
Nadolol—Vomiting—Vinblastine—head and neck cancer	0.0058	0.0058	CcSEcCtD
Nadolol—Anorexia—Fluorouracil—head and neck cancer	0.00571	0.00571	CcSEcCtD
Nadolol—Diarrhoea—Hydroxyurea—head and neck cancer	0.00569	0.00569	CcSEcCtD
Nadolol—Hypotension—Fluorouracil—head and neck cancer	0.00559	0.00559	CcSEcCtD
Nadolol—Dizziness—Hydroxyurea—head and neck cancer	0.0055	0.0055	CcSEcCtD
Nadolol—Nausea—Vinblastine—head and neck cancer	0.00542	0.00542	CcSEcCtD
Nadolol—Insomnia—Fluorouracil—head and neck cancer	0.00541	0.00541	CcSEcCtD
Nadolol—Paraesthesia—Fluorouracil—head and neck cancer	0.00538	0.00538	CcSEcCtD
Nadolol—Alopecia—Docetaxel—head and neck cancer	0.00537	0.00537	CcSEcCtD
Nadolol—Dyspnoea—Fluorouracil—head and neck cancer	0.00534	0.00534	CcSEcCtD
Nadolol—Vomiting—Hydroxyurea—head and neck cancer	0.00529	0.00529	CcSEcCtD
Nadolol—Dyspepsia—Fluorouracil—head and neck cancer	0.00527	0.00527	CcSEcCtD
Nadolol—Rash—Hydroxyurea—head and neck cancer	0.00524	0.00524	CcSEcCtD
Nadolol—Dermatitis—Hydroxyurea—head and neck cancer	0.00524	0.00524	CcSEcCtD
Nadolol—Decreased appetite—Fluorouracil—head and neck cancer	0.0052	0.0052	CcSEcCtD
Nadolol—Pain—Fluorouracil—head and neck cancer	0.00512	0.00512	CcSEcCtD
Nadolol—Nausea—Hydroxyurea—head and neck cancer	0.00494	0.00494	CcSEcCtD
Nadolol—Syncope—Docetaxel—head and neck cancer	0.00475	0.00475	CcSEcCtD
Nadolol—Body temperature increased—Fluorouracil—head and neck cancer	0.00473	0.00473	CcSEcCtD
Nadolol—Loss of consciousness—Docetaxel—head and neck cancer	0.00465	0.00465	CcSEcCtD
Nadolol—Cough—Docetaxel—head and neck cancer	0.00462	0.00462	CcSEcCtD
Nadolol—Hypertension—Docetaxel—head and neck cancer	0.00457	0.00457	CcSEcCtD
Nadolol—Chest pain—Docetaxel—head and neck cancer	0.00451	0.00451	CcSEcCtD
Nadolol—Dry mouth—Docetaxel—head and neck cancer	0.00441	0.00441	CcSEcCtD
Nadolol—Oedema—Docetaxel—head and neck cancer	0.00432	0.00432	CcSEcCtD
Nadolol—Shock—Docetaxel—head and neck cancer	0.00425	0.00425	CcSEcCtD
Nadolol—Pruritus—Fluorouracil—head and neck cancer	0.00424	0.00424	CcSEcCtD
Nadolol—Anorexia—Docetaxel—head and neck cancer	0.00412	0.00412	CcSEcCtD
Nadolol—Diarrhoea—Fluorouracil—head and neck cancer	0.0041	0.0041	CcSEcCtD
Nadolol—Hypotension—Docetaxel—head and neck cancer	0.00404	0.00404	CcSEcCtD
Nadolol—Dizziness—Fluorouracil—head and neck cancer	0.00396	0.00396	CcSEcCtD
Nadolol—Insomnia—Docetaxel—head and neck cancer	0.00391	0.00391	CcSEcCtD
Nadolol—Paraesthesia—Docetaxel—head and neck cancer	0.00388	0.00388	CcSEcCtD
Nadolol—Dyspnoea—Docetaxel—head and neck cancer	0.00385	0.00385	CcSEcCtD
Nadolol—Vomiting—Fluorouracil—head and neck cancer	0.00381	0.00381	CcSEcCtD
Nadolol—Dyspepsia—Docetaxel—head and neck cancer	0.0038	0.0038	CcSEcCtD
Nadolol—Rash—Fluorouracil—head and neck cancer	0.00377	0.00377	CcSEcCtD
Nadolol—Dermatitis—Fluorouracil—head and neck cancer	0.00377	0.00377	CcSEcCtD
Nadolol—Decreased appetite—Docetaxel—head and neck cancer	0.00376	0.00376	CcSEcCtD
Nadolol—Fatigue—Docetaxel—head and neck cancer	0.00373	0.00373	CcSEcCtD
Nadolol—Pain—Docetaxel—head and neck cancer	0.0037	0.0037	CcSEcCtD
Nadolol—Constipation—Docetaxel—head and neck cancer	0.0037	0.0037	CcSEcCtD
Nadolol—Nausea—Fluorouracil—head and neck cancer	0.00356	0.00356	CcSEcCtD
Nadolol—Body temperature increased—Docetaxel—head and neck cancer	0.00342	0.00342	CcSEcCtD
Nadolol—Asthenia—Docetaxel—head and neck cancer	0.0031	0.0031	CcSEcCtD
Nadolol—Pruritus—Docetaxel—head and neck cancer	0.00306	0.00306	CcSEcCtD
Nadolol—Diarrhoea—Docetaxel—head and neck cancer	0.00296	0.00296	CcSEcCtD
Nadolol—Dizziness—Docetaxel—head and neck cancer	0.00286	0.00286	CcSEcCtD
Nadolol—Vomiting—Docetaxel—head and neck cancer	0.00275	0.00275	CcSEcCtD
Nadolol—Rash—Docetaxel—head and neck cancer	0.00272	0.00272	CcSEcCtD
Nadolol—Dermatitis—Docetaxel—head and neck cancer	0.00272	0.00272	CcSEcCtD
Nadolol—Nausea—Docetaxel—head and neck cancer	0.00257	0.00257	CcSEcCtD
